Concepedia

Author

James W. Vardiman

University of Chicago

Also Known As

J Vardiman, J W Vardiman, James Vardiman, James W Vardiman, James W. VARDIMAN, James W. Vardiman, Tomoko Hata

161

Publications

33.3K

Citations

59

H-Index

84

Concepts

All Affiliations

University of ChicagoRoswell Park Comprehensive Cancer CenterThe Ohio State UniversityNorth Shore University HospitalDana-Farber Cancer Institute
JW

About

James W. Vardiman is an author at University of Chicago specializing in pathology, medicine, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

31

2.5K

2

Health Sciences

8

8

1.4K

3

Public Health

1

1

396

4

Allergy

1

1

63

5

Biostatistics

1

1

106

James W. Vardiman

×

76

Publications

13.3K

Citations

49

H-Index

YearCitations

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Nancy L. Harris, Elaine S. Jaffe, J Diébold,

Journal of Clinical Oncology

1999

3.3K

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Ayalew Tefferi, Jüergen Thiele, Attilio Orazi,

Blood

2007

857

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Sonali M. Smith, Michelle M. Le Beau, Dezheng Huo,

Blood

2003

674

Adverse Prognostic Significance of <i>KIT</i> Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

Peter Paschka, Guido Marcucci, Amy S. Ruppert,

Journal of Clinical Oncology

2006

660

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

Wendy Stock, Mei La, Ben L. Sanford,

Blood

2008

527

Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic Leukemia

Michelle M. Le Beau, Richard A. Larson, Mitchell A. Bitter,

New England Journal of Medicine

1983

496

Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia

Richard A. Larson, Koji Kondo, James W. Vardiman,

The American Journal of Medicine

1984

426

The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

Nancy L. Harris, Elaine S. Jaffe, J Diébold,

Modern Pathology

2000

396

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Guido Marcucci, Krzysztof Mrózek, Amy S. Ruppert,

Journal of Clinical Oncology

2005

381

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

Sherif S. Farag, Kellie J. Archer, Krzysztof Mrózek,

Blood

2006

329

Page 1